정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 499 | Active, not recruiting | Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure | COVID-19 | Drug: Standard Therapy Protocol (STP) Other: STP + Standard Plasma (SP) Other: STP + COVID-19 Convalescent Plasma (CP) |
Phase 2 | Azienda Ospedaliera Citta della Salute e della Scienza di Torino | OTHER | 180 | All | 18 Years | AO Citta della salute e della scienza di Torino, Torino, Italy |
| 498 | Recruiting | Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID) | Thrombosis | Drug: Tinzaparin | Phase 3 | Hospital Universitario Infanta Leonor | OTHER | 600 | All | 18 Years | Complejo Hospitalario Universitario A Coruna, A Coruna, Spain Hospital Universitario del Vinalopo, Alicante, Spain Hospital Clinic Barcelona, Barcelona, Spain Hospital Universitario Vall d'Hebron, Barcelona, Spain Hospital Universitario de Burgos, Burgos, Spain Hospital Virgen de la Luz, Cuenca, Spain Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain Hospital Clinico San Carlos, Madrid, Spain Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain Hospital General Universitario Gregorio Maranon, Madrid, Spain Hospital Universitario 12 Octubre, Madrid, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Infanta Sofia, Madrid, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain Hospital Clinico Universitario de Valencia, Valencia, Spain Hospital Clinico Universitario de Valladolid, Valladolid, Spain Hospital Alvaro Cunqueiro, Vigo, Spain |
| 497 | Not yet recruiting | Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy | Neurocognitive Impairment, Mild | Drug: Atorvastatin Other: Standard Care |
Phase 3 | The George Institute, University of Sydney, Monash University, The Alfred, Universidad del Desarrollo | OTHER | 400 | All | 18 Years | The George Institute for Global Health, Sydney, New South Wales, Australia |
| 496 | Not yet recruiting | Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19 | Convalescent Plasma | Biological: Convalescent plasma | Phase 2 | Universidad Autonoma de Coahuila, National Council of Science and Technology, Mexico | OTHER | 15 | All | 18 Years | Hospital Universitario "Dr. Gonzalo Valdes Valdes", Saltillo, Coahuila, Mexico |
| 495 | Completed | Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia | Pneumonia | Drug: Methylprednisolone Other: Usual Care |
Phase 2 | Mayo Clinic | OTHER | 44 | All | 18 Years | Mayo Clinic in Rochester, Rochester, Minnesota, United States |
| 494 | Recruiting | Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection | Coagulopathy | Drug: Enoxaparin Drug: Methylprednisolone Drug: unfractionated heparin |
Phase 3 | Massimo Girardis | OTHER | 210 | All | 18 Years | ICU- University Hospital Modena, Modena, Italy |
| 493 | Terminated | STerOids in COVID-19 Study | Coronavirus Infection | Drug: Budesonide dry powder inhaler | Phase 2 | University of Oxford | OTHER | 146 | All | 18 Years | Oxford Respiratory Trials Unit, Oxford, Oxfordshire, United Kingdom |